Background:
Introduction
According to The Central Brain Tumor Registry of the United States (CBTRUS), the incidence rate of all primary brain and central nervous system (CNS) tumors is 16.5 cases per 100,000 person-years (9.2 per 100,000 person-years for non-malignant tumors and 7.3 per 100,000 person-years for malignant tumors) 1 . The prevalence rate for all primary brain and central nervous system tumors was estimated to be 130.8 per 100,000 inhabitants 1 . Metastatic brain tumors are thought to have a higher incidence than primary brain tumors 2 .
The cornerstone of brain tumor treatment is surgery. The objective of surgery is to remove as much tumor as possible, as well as to establish an exact tissue diagnosis.
The possible benefits of tumor removal include symptom relief, improved quality of life, smaller tumor burden for other treatment modalities and improved survival [3] [4] [5] [6] [7] [8] [9] .
However, craniotomies are not without inherent risks, be it surgical mortality 10, 11 , postoperative hematomas 12, 13 or infection 14 . With respect to surgical mortality, the reported series are often of limited size 15 and based on a selected patient group 16 . Furthermore, to ascertain surgical deaths, either death before discharge (in-hospital mortality) or within 30 days of surgery is used, with the former missing more than 25% of surgery-related deaths and creates potential for bias across institutions (John D. Birkmeyer, personal communication). With respect to intracranial hematomas, the consequences are often devastating, with a mortality rate of 30% and a significant morbidity rate 17 . With respect to infections after neurosurgical procedures, these often present as meningitis, subdural empyema, or cerebral abscess. Although meningitis can often be treated with intravenous antibiotics, cases that involve a bone flap infection, subdural empyema, or cerebral abscess usually require a repeated operation.
In order to weigh the risks of surgery against the presumed advantages, it is important to have specific knowledge about the institution's complication rate. We therefore wanted to determine the 30 day surgical mortality rate as well as the rate of postcraniotomy hematomas and infections that required reoperation, reviewing our pro- 
Materials and methods

Patients
The defined neurosurgical catchment area for Oslo University Hospital is the south and eastern health region of Norway. It has 2.7 million inhabitants (56% of the Norwegian population) and Oslo University Hospital treat approximately 99% of the neurosurgical tumor patients within this region (The Norwegian Cancer Registry, unpublished data). All patients ≥18 years who underwent craniotomy for an intracranial tumor at the two departments of Oslo University Hospital (Rikshospitalet and Ullevål) in the time period 2003 -2008 were included in this study. Thus, this study can also serve as a population study in terms of incidence of craniotomies for particular tumor types in Norway. Patients who underwent stereotactic biopsy were not included.
The patients were identified from our prospectively collected database and their charts were studied retrospectively. The following data were recorded: sex, age, biopsy or resection, primary or secondary (repeated) surgery, histology, reoperation for postoperative hematoma, and reoperation for deep postoperative infection (infected bone flap, epidural abscess, subdural empyema or intracerebral abscess).
Superficial wound infections that required simple wound revision were not included. The charts of the patients who died within 30 days, or who were reoperated for hematoma or infection, were studied more thoroughly. The cause of death for those who died within 30 days was recorded as directly surgery-related (SR), i.e. hemorrhage or postoperative edema with subsequent herniation, or not surgeryrelated (NSR), i.e. either tumor progression-related, systemic complications, or other causes. The time from initial surgery to reoperation for hematoma or infection was recorded. The long-term outcome for those reoperated for hematoma or infection was determined, based on preoperative status, postoperative recovery, both after the original craniotomy and reoperation, and status at follow-up contacts with the hospital. The patient's condition at follow-up was compared with the patient's expected disability had he not suffered such complications, thus giving an estimate of additional disability likely caused by the hematoma or infection. The following scale was used: no additional disability, minor additional disability, major additional disability, and death.
The major histological groups were used (Table 1) 
Perioperative routines
A consultant anesthetist sees all our patients preoperatively. Elderly patients (>70 years) and patients on multiple medications are routinely also seen by consultant internist, to optimize the general medical condition and medications. Patients with a known heart condition are referred to cardiologist for cardiac ultrasound and ECG stress test. Patients with a past hematological history are referred to a consultant hematologist. Aspirin is stopped at least 10 days prior to surgery and when on anticoagulation, the INR should be below 1.5. All patients receive compressive stockings the day before surgery and keep them until fully mobilized. At initiation of surgery, a second-generation cephalosporin is administered intravenously and continued every 90 minutes until the case is completed or the maximum daily dose of 8 grams is reached. For long cases, erythromycin or a third-generation cephalosporin is started after the maximum daily dose of a second-generation cephalosporin is reached and continued until completion of the case. Postoperatively, the patients are observed in the recovery for 3-6 hours, whereafter they are transferred to a level 2 bed. After a craniotomy for a supratentorial tumor, the patients are generally observed for 24 hours. For infratentorial tumors, the length of observation is minimum 48 hours. Low-molecularweight heparin is given the first postoperative day. The patients are mobilized either in the afternoon at the day of surgery or on the first postoperative day.
Ethics
The hospitals´ Data Protection Officials approved the study.
Statistics
Uni-and multivariate logistic regression was used to determine the impact of the different independent variables on 30 day mortality, postop hematoma and postop infection. The independent variables were binary except for histology where high grade glioma was used as the reference category against which all other histology classes were compared. The fit of the multivariate models were investigated and reported using Pseudo-R2 and the Hosmer-Lemeshow goodness-of-fit test. P-values less than 0.05 were considered significant. Stata v10.1 (Stata Corp, Austin, Tx) was used for all statistical analyses.
Results
Patient population
A total of 2630 consecutive craniotomies at the Oslo University Hospital in the time period 2003-2008 were included in this study ( Table 1 ). The mean age at surgery was 56 years (range 18-89 years), with a male-to-female ratio of 1:1.06. Follow-up was 100%.
Incidence of craniotomies
First-time craniotomies with primary resection were performed in 2073 cases, 483 cases were reoperations with repeated resection, and 74 cases were open biopsies.
Thus, the incidence of first-time craniotomy for a brain tumor was 12.8 /100 000 inhabitants per year and for a repeat resection 3.0 /100 000 inhabitants per year.
Surgical mortality
The surgical mortality, defined as death within 30 days of surgery, was 2.3% (n=60).
The cause of death was postoperative hematomas in 21 cases (35.0 %), tumor progression in 21 (35.0%), infectious diseases in 8 cases (13.3%), postoperative edema and subsequent herniation in 4 cases (6.7%), and other causes in 6 cases (10%) ( Table 2 ). The surgical mortality rate for HGG, LGG, meningiomas and metastases, was 2.9% (n=24), 1.0% (n=3), 0.9% (n=6) and 4.5% (n=20), respectively.
Using multivariate Cox regression analyses, age>60 (Odds ratio (OR) 1.84, 95%CI
(1.05, 3.22) , p<0.05) and biopsy compared to resection (OR 4.67, 95%CI (1.80, 12.14) p<0.01) were shown to be significantly associated with increased surgical mortality ( Table 3) . Compared to HGG, metastases were associated with a higher mortality in the univariate analysis (p<0.01), but this did not reach significance in the multivariate analysis. Compared to HGG, meningiomas were associated with a lower surgical mortality (p<0.05).
Postoperative hematomas requiring recraniotomy
The total occurrence of surgically evacuated postoperative hematomas was 2.1% (n=54) ( Table 4) . Of the 54 evacuated hematomas, 23 (42.6%) were intra-cerebral (ICH), 13 (24.1%) were acute epidural (EDH), 2 (3.7%) were acute subdural (aSDH), 4 (7.4%) were intracerebellar, 1 (1.9%) was in the brain stem, 8 (14.8%) were chronic subdural hematomas (cSDH), and 3 (5.6%) were subcutaneous (SC) ( Table 4) .
Risk factors for reoperation for postoperative hematomas
Using multivariate Cox regression analyses, age>60 was shown to be significantly associated with increased risk of developing postoperative hematoma (OR 2.43 95% CI (1.35,4.39), p<0.001) ( Table 3 ). Neither sex, resection vs. biopsy, primary vs. secondary craniotomy, nor tumor type were significantly associated with risk of developing postoperative hematoma. The occurrence of postoperative hematoma was: HGG 2.0% (n=17), LGG 0.7% (n=2), meningiomas 2.3% (n=16), metastases
2.2% (n=10).
Time to reoperation for postoperative hematomas
The surgically evacuated hematomas were reoperated within 6 hours in 11 cases Table   4 ). Four patients were operated between day 3 and day 7 after surgery, 3 patients were operated between day 7 and day 30, and 7 patients after 30 days of surgery. All 7 in the latter group were cSDH. Excluding the cSDHs, the median time from tumor surgery to reoperation for hematoma was 1 day (mean 2.2 days, range 0-26).
Consequences of postoperative hematoma
Twenty patients (37.0 %) had no additional disability, 16 (29.6 %) had minor additional disability, 4 (7.4 %) had major additional disability, and 12 (22.2 %) died due to their hematoma. Long-term data are inconclusive for 2 patients (3.7 %). Six out of twenty-three (26.1 %) patients with ICH died, while 2/13 (15.4 %) patients with EDH died (p>0.05) ( Table 4 ).
Postoperative infection requiring recraniotomy
A total of 39 patients (1.5%) were reoperated for deep postoperative infection (Table   5) . Of these infections, 23 (59.0 %) were extradural (ED), 6 (15.4 %) intradural (ID), and 10 (25.6 %) were both intra-and extradural.
Risk factors of reoperation for postoperative infection
Multivariate Cox regression analysis demonstrated that meningiomas had an increased risk of infection compared to gliomas (odds ratio 5.88, 95%CI (2.47,13.87), p<0.001) ( Table 3) . Men also had an increased risk of infections (p<0.01). Neither resection vs. biopsy, nor primary vs. secondary craniotomy were significantly associated with risk of developing postoperative deep infection. The postoperative infection rate was 1.0% (n=8) for HGG, 0.0% (n=0) for LGG, 3.2% (n=22) for meningiomas, and 1.1% (n=5) for metastases.
Time to reoperation for postoperative infection
The median time from tumor surgery to reoperation for infection was 42 days (mean 95.7 days, range 16-667 days). The number of patients who were reoperated within 1, 2, 3, 6 and 12 months, were 11 (28.2%), 27 (69.2%), 29 (74.4%), 32 (82.1%) and 37 (94.9%), respectively.
Consequences of postoperative infection
Of the 39 patients with deep infection, 29 (74.4 %) had no additional disability, 5 (12.8 %) had minor additional disability, 3 (7.7 %) had major additional disability, 2 (5.1 %) died due to the infection (Table 4) .
Discussion Epidemiology
The neurosurgical catchment area for Oslo University Hospital (OUH) is well-defined, consisting of 2.7 million inhabitants (56% of the Norwegian population) and with very little loss of patients (1%) to other health regions or countries (The Norwegian Cancer Registry, unpublished data). As all patients ≥18 years who underwent craniotomy for an intracranial tumor at OUH within a defined time period of 6 years were included in this study, it can serve as a population study in terms of incidence of craniotomies for particular tumor types in the Norwegian population. The incidence of first-time craniotomy for a brain tumor was 12.8 /100 000 inhabitants per year and for a repeat resection 3.0 /100 000 inhabitants per year.
Surgical mortality at 30 days
The overall surgical mortality in this series was 2.3%. The incidence of surgical mortality after craniotomy for tumors is previously reported to be between 0 and 9.6%, varying with the diagnosis 10, 15, [18] [19] [20] [21] [22] [23] [24] [25] [26] . Long et al. 23 reported in 2003 a mortality rate at high-volume hospitals (>50 craniotomies/year) of 2.5% after craniotomy for various intracranial tumors, both benign and malignant. Barker et al. 20 reported in their series of primary supratentorial brain tumors a mortality rate of 2.9%. However, both these studies were in-hospital mortality rates, whereas we report a 30-day mortality rate. Nevertheless, our mortality rates are comparable to, or even lower than, most published rates.
The causes of surgical mortality include complications to surgery and factors not directly related to surgery, as well as other factors, like tumor progression or other morbidity. Several risk factors are associated with increased hazard of death, e.g. advanced age 10, 15, 20, 24 , a low preoperative KPS score 15 , and comorbidity 10, 20 .
Several of the complications are avoidable, and should be paid close attention to.
Postoperative hematomas carry a high mortality rate 17 . In our series, hematomas were suspected to be the cause of, or significant contributor to, 35% of the deaths within 30 days of surgery. Consequently, avoiding hematomas is the single most important factor to reduce surgical mortality.
Pulmonary embolism (PE) has an incidence rate of between 1.5 and 3%, and a mortality rate between 9 and 50%, and is a frequent cause of death among neurosurgical patients 27 . In our study, one patient died from a PE postoperatively.
The prevention of PE in neurosurgical patients is controversial, as the commonly used medical prophylaxis, i.e. unfractioned or low-molecular-weight heparin, may increase the rate of intracranial bleeding, with its deleterious effects 28 . Danish et al.
showed that mechanical prophylaxis yields outcomes in craniotomy patients superior of those of heparin 28 , but the field remains controversial. In our practice, patients with a past hematological history are referred to a consultant hematologist, all patients receive compressive stockings the day before surgery and keep them until fully mobilized. Low-molecular-weight heparin is given the first postoperative day. The patients are mobilized very early, either the same afternoon or on the first postoperative day.
Age is an independent risk factor for surgical mortality. Still, age should not be used as a selection criterion for surgery for intracranial tumors alone 29 . A careful selection among patients with a low preoperative KPS score and with comorbidity should be carried out to lower operative mortality rates.
In our series, undergoing open biopsy was significantly associated with 30-day mortality, a finding that probably has more to do with a selection bias that favors good candidates for resection, while those undergoing biopsy already have a poorer prognosis. A total of 74 patients underwent open biopsy ( Table 1) . Seven of these patients died within 30 days postoperatively (9.5%), the majority of whom (5 of 7, or 71.4%) died due to tumor progression (Table 2 ).
In our series, meningiomas had a significantly lower 30-day mortality rate than HGG and metastases, with a rate of 0.9% vs. 2.9% and 4.5%. One factor contributing to this difference might be that all 6 deaths in the meningioma group were surgeryrelated, while several deaths in the other groups were non-surgery related. However, this factor alone does not explain the discrepancy, indicating that the inherent risk of undergoing a craniotomy will in fact vary according to the diagnosis.
Postoperative hematomas requiring reoperation
In our series, we found a rate of postoperative hematomas of 2.1%. This includes 3 subcutaneous hematomas and 8 cSDH. Other studies have reported a hematoma rate of 0.6-4.0% 15, 18-22, 25, 26, 29, 30 .
Risk factors
Advanced age was significantly associated with development of postoperative hematoma, in both uni-and multivariate analyses. This finding is supported by other studies 13, 17, 31 and has been attributed to tissue fragility observed in the elderly 28 .
Palmer et al. 17 showed in their series of 6668 intracranial procedures an increased risk of postoperative hematoma for meningiomas compared with intrinsic tumors. We did not find an association between histology and risk of postoperative hematoma.
In the aforementioned series, Palmer et al. 17 identified several risk factors associated with postoperative hematoma, including thrombocytopenia, anticoagulants, a history of heavy alcohol intake, coagulopathy, malignancy outside the central nervous system, and the administration of antiplatelet agents during the 2 weeks preceding surgery. Administration of antiplatelet agents was the most frequent risk factor, being used by 43% of those reoperated for hematoma 17 . In our practice, patients with a past hematological history are referred to a consultant hematologist, aspirin is stopped at least 10 days prior to surgery and when on anticoagulation, the INR should be below 1.5. Low-molecular-weight heparin is not given until the first postoperative day.
Mortality rate of postoperative hematomas
The reported mortality rate of postoperative hematomas is 18-32% 17, 32, 33 . We found a mortality rate of 22%, with an additional 2% being severely disabled due to the hematoma. Consequently, postoperative hematomas may have deleterious consequences and it is utmost important to reduce or eliminate as many risk factors as possible, and thereby reducing the incidence of postoperative hematomas.
Vassilouthis et al. hematoma cases. They concluded that a 6-hour observation period in the recovery area/intensive care unit after craniotomy before transfer to further nursing on a neurosurgical ward should be sufficient for most patients, but they recommended longer observation times after emergency craniotomies and posterior fossa surgery.
In our series, only 11 patients (25%) were reoperated within 6 hours, indicating that a 6-hour observation period in recovery may be insufficient to sift out the majority of the patients in need of emergency surgery for a postoperative hematoma. However, close observation on a specialized neurosurgical ward may overcome this problem.
Furthermore, our results indicate that a patient undergoing a craniotomy should be observed closely for a total of at least 48 hours postoperatively, as 80% of our patients that needed a recraniotomy for postoperative hematoma are operated within 2 days.
Postoperative infections requiring reoperation
Contemporary neurosurgical series have reported an incidence of postoperative infections after craniotomy of 0.6-6.6% 18, 19, 30, [35] [36] [37] , although some of these series have included non-operative cases as well. Our rate of postoperative infections requiring surgical treatment was in this study 1.5%, thus being in the lower end of the scale.
Risk factors
We observed a statistically significant association between male gender and postoperative infections. This has not been noted in other large neurosurgical series [38] [39] [40] , but Korinek et al. 41 observed an increased risk of nosocomial meningitis after craniotomy in males. At present, we have no explanation for our finding.
Meningioma surgery was significantly associated with development of postoperative infection in both uni-and multivariate analyses. This was also shown by Korinek et al. 35 in 2005, although only in univariate analysis. They attributed this to hemostasis and closure difficulties in meningioma surgery. Korinek et al. 35 also showed an association between infection and surgery duration over 4 hours, a finding that also has been demonstrated by others 42, 43 . As meningioma operations are often time -consuming procedures, this might be a contributing factor to the higher incidence of infections after meningioma surgery.
Korinek et al. 35 studied the effect of antibiotic prophylaxis (ABP) on neurosurgical site infections after craniotomy for various reasons, e.g. tumor surgery, vascular surgery, and trauma surgery. Among the 4578 patients studied, 77 (1.7%) developed bone flap osteitis, and 126 (2.7%) developed brain abscess or subdural empyema, for a total of 4.4%. As patients with both osteitis and abscess/empyema were counted once in each group, the number of patients with infections was a bit lower. ABP significantly reduced the incidence of bone flap osteitis (3.1% in patients with no ABP and 1.3% in patients with ABP, p<0.0002) and abscess/empyema (5.6% versus 2.0%, p<0.0001). In our practice, we use a second-generation cephalosporin i.v. at initiation of surgery and continued every 90 minutes until the case is completed or the maximum daily dose of 8 grams is reached, whereafter erythromycin or a thirdgeneration cephalosporin is started and continued until completion of the case.
Consequences of postoperative infection
The consequences of postoperative infection are not at all as severe as the consequences of postoperative hematoma. In our series, 2 patients (5%) died due to the infection, while 33 (85%) had a good outcome, with no or only a mild disability (Table 2) . It is important to point out that we did not include patients with meningitis.
Timing of postoperative infection development
In our series, almost 75% of the patients with infection were reoperated within 3 months of tumor surgery. Korinek et al. 35 showed a mean time between surgery and onset of infection of 118±157 days for bone flap osteitis, and 25±27 days for brain abscesses or subdural empyema. Dashti et al. 36 reported a median duration between craniotomy and presentation of postoperative infection of 1.5 months (range 4 days-5 years). In our series, most postoperative infections requiring reoperation occur within 3 months of surgery, but some infections, in particular bone flap osteitis, may occur later than 1 year after surgery, reportedly as late as 5 years later 43, 44 .
Strengths of the study
The strengths of this study lie in the setting, design and follow-up. The data were restricted to one health centre only (Oslo University Hospital), thereby reducing the possible confounding effect of differences in the access to health care services between health centers. Thus, we have avoided the selection bias inherently present in large multi-center studies, as there are only two neurosurgical units performing these surgeries in a geographically well-defined area. As Dashti et al. 36 pointed out, it is reasonable to assume that a number of patients with postoperative infection were not included in their study if they presented to, and were subsequently treated at, other facilities than the one where they were operated in the first place. They also point out that this number might be high, but that there is no way to determine how high 36 . This problem may have occurred in several of the other studies as well.
Furthermore, our data were prospectively registered in a database. As the study includes all craniotomies performed for a histologically verifiable brain tumor, there is no selection bias. The study is contemporary, thereby reflecting current neurosurgical practice and was performed within a relatively short time span, thereby reducing confounding factors as changes in antibiotic prophylaxis regimen or operating theatres. With respect to data, we only used end points that are easily verifiable (mortality, reoperation for hematomas, reoperations for infections). Lastly, we obtained 100% follow-up. To the best of our knowledge, our study is the largest study with regard to postoperative complications within 30 days of craniotomy for brain tumors. Previous studies are either smaller than our study, or they use in-hospital mortality rates.
Limitations of the study
The first limitation of the study is the retrospective design. Secondly, the follow-up on some patients may be too short with regard to postoperative infections, as bone flap infections may occur later than 1 year after surgery.
Conclusions
The annual incidence of first-time craniotomy for a brain tumor was 12.8 /100 000 inhabitants. The mortality rate, rate of postoperative hematomas and infections were low. Although advanced age was significantly associated with a higher 30-day surgical mortality and risk of postoperative hematomas, surgery in selected elderly patients is worthwhile and not futile. The single most important way to reduce surgical mortality is avoidance of postoperative hematomas.
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